Investor Presentaiton
CRLS Key Business Updates (Cont'd)
Decentralized Clinical Trials ("DCTS"
In the first half of 2023, Tigermed Decentralized Clinical Trials
("DCTS") Solutions were fully or partially applied in multiple
projects covering therapeutic areas such as oncology, Alzheimer's
disease, migraine, diabetes and COVID-19 etc. We created
functions such as remote follow-up, remote monitoring, remote
informing, electronic patient report, wearable devices etc.
We compiled The Tigermed DCT Global Regulatory Handbook, to
provide a regulatory reference and guide for DCT applications in
global clinical research, which will be released soon
• We are developing DCT eConsent, E2E, CTCM, and other
systems. After completion and putting into use, these systems will
make the DCT service platform more comprehensive and flexible
to provide customers with decentralized clinical trial solutions.
We participated in multiple regulatory and industry projects and
seminars on the construction of decentralized clinical trial
regulations
L
DHT/Digital
Medicine
eConsent
¿Ð
eCOA/ePRO
/eDiary
/IRT/DTP
-.
E
E2E
Tigermed
DCT
Platform
EDC
Al Follow up
眉
eCPM
eTMF
CTMS
000
RBQM
ePAY
B
CTRM/CTC
M
• Tigermed
21
224View entire presentation